• 목록
• 게시판 리스트 옵션
  • 수정
  • 삭제

P = 0.001, **p < 0.P019 Relation between adrenomedullin and short-term outcome in ICU patients: Results from the frog ICU study E. G. Gayat1, J. Struck2, A. Cariou3, N. Deye1, B. Guidet4, S. Jabert5, J. Launay1, M. Legrand6, M. L ne7, M. Resche-Rigon6, E. Vicaut1, A. Vieillard-Baron8, A. Mebazaa1 1 H ital Lenvatinib Lariboisi e, Paris, France; 2Sphingotec, Berlin, Germany; 3H ital Cochin, Paris, France; 4H ital Saint-Antoine, Paris, France; 5CHRU de Montpellier, Montpellier, France; 6H ital Saint-Louis, Paris, France; 7 AP-HM, Marseille, France; 8H ital Ambroise Par? Paris, France Significant Treatment 2016, twenty(Suppl 2):P019 Introduction: Adrenomedullin (ADM) can be a peptide with 52 amino acids that has sturdy vasodilator activity. Elevated plasma ADM concentrations have already been detected within a wide variety of physiological and pathological situations, with PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/22763976 the very best elevations noticed in septic shock. Marino et al. shown a strong affiliation of admission ADM stages with the severity of sepsis, supporting an earlier report describing elevated ADM degrees in all those with severe sepsis and those with septic shock [1]. By utilizing a novel assay specific for bioactive ADM (bio-ADM) as Marino et al.the intention from the research was to assess the relation amongst ADM calculated at admission and in-ICU mortality in consecutive sufferers no matter the reason for admission. Methods: The French and euRopean Result reGistry in Intense Treatment Models (FROG-ICU) research was a multicenter observational study, such as 2087 consecutive sufferers adopted approximately just one year for people who survived to ICU keep. The protocol has earlier been described [2]. Plasma were gathered at admission for all people and at discharge for in-ICU survivors. ADM was measured in all plasma utilizing a sandwich assay particular for bio-ADM. The affiliation involving inICU mortality and the volume of ADM was assessed by univariate examination and altered examination for severity at admission measured through the SAPS-II. Improvement in spot under the ROC curve and reclassification indices ended up assessed. Results: 2087 people happen to be included, sixty five male having a median age of sixty three (51-74), a median Charlson rating of 3 (1-5) and also a median SAPS-II forty nine (36-63). Septic shock was existing in 488 (23 ) patients. Median (and interquartile variety) of ADM in-ICU survivors and nonsurvivors was 57 pg/mL [30-114] and 110 pg/mL [63-220], respectively (p < 0.001). Hazard ratio of in-ICU death for patients with a level of ADM higher than the median value was 2.12 (95 CI: 1.73-2.60) and 1.68 (95 CI: 1.36-2.07) when adjusted for SAPS-II. Area under the ROC curve of SAPS-II was significantly improved by the addition of ADM (0.653 [0.624 - 0.682] to 0.702 [0.675 - 0.729], p = 0.01). Conclusions: In the present study, ADM was independently associated with in-ICU mortality and improved prognostic prediction. The clinical and therapeutic implication of these findings need to be further investigated.References [1] R Marino et al. Critical Care 2014, 18:R34 [2] Mebazaa et al. BMC Anesthesiology (2015) 15:P020 Impact of disease severity assessment on performance of heparinbinding protein for the prediction of septic shock R. Arnold1, M. Capan1, A. Linder2, P. Akesson2 1 Christiana Care Health System, Newark, USA; 2Skane University Hospital, Lund University, Lund, Sweden Critical Care 2016, 20(Suppl 2):PCritical Care 2016, Volume PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/9547713 twenty SupplPage twenty ofIntroduction: Prognostic biomarkers for sepsis are described regardless of individual severity. Our aim was to desc.